| RLAYRelay Therapeutics, Inc. | 17,000,000 | $169.2M |
| ALKSAlkermes plc. | 4,200,000 | $148.5M |
| ELVNEnliven Therapeutics, Inc. | 3,275,000 | $128.4M |
| COGTCogent Biosciences, Inc. | 2,888,007 | $111.2M |
| SYRESpyre Therapeutics, Inc. | 1,912,380 | $96.5M |
| TYRATyra Biosciences, Inc. | 2,475,000 | $94.8M |
| CLDXCelldex Therapeutics, Inc. | 2,696,616 | $85.5M |
| NUVLNuvalent, Inc. | 833,600 | $85.4M |
| AMLXAmylyx Pharmaceuticals, Inc. | 5,650,000 | $78.5M |
| KYMRKymera Therapeutics, Inc. | 750,000 | $62.5M |
| ANROAlto Neuroscience, Inc. | 2,723,196 | $61.2M |
| PHVSPharvaris N.V. | 1,918,970 | $54.2M |
| ERASErasca, Inc. | 3,175,000 | $51.4M |
| DMRADamora Therapeutics, Inc. | 1,939,000 | $50.2M |
| XENEXenon Pharmaceuticals Inc. | 825,000 | $48.0M |
| DFTXDefinium Therapeutics Inc. | 2,000,000 | $37.8M |
| LBRXLB PHARMACEUTICALS INC | 1,500,000 | $37.0M |
| NRIXNurix Therapeutics, Inc. | 2,275,000 | $35.3M |
| CRVSCorvus Pharmaceuticals, Inc. | 2,258,735 | $33.0M |
| ASMBASSEMBLY BIOSCIENCES, INC. | 1,000,000 | $27.8M |
| CATXPerspective Therapeutics, Inc. | 6,336,782 | $26.4M |
| SLNOSOLENO THERAPEUTICS INC | 652,432 | $21.8M |
| OCULOCULAR THERAPEUTIX, INC | 2,575,000 | $21.8M |
| IPSCCentury Therapeutics, Inc. | 8,695,652 | $19.7M |
| ZURAZura Bio Ltd | 3,250,000 | $19.3M |
| SABSSAB BIOTHERAPEUTICS, INC. | 4,401,500 | $16.9M |
| PALIPALISADE BIO, INC. | 7,181,062 | $12.6M |
| KPTIKaryopharm Therapeutics Inc. | 1,950,000 | $10.9M |
| IKTInhibikase Therapeutics, Inc. | 5,397,488 | $9.1M |
| ANTXAN2 Therapeutics, Inc. | 2,333,713 | $8.0M |
| PEPGPepGen Inc. | 4,475,000 | $7.9M |
| AVTXAvalo Therapeutics, Inc. | 483,000 | $7.2M |
| LONALeonaBio, Inc. | 464,398 | $4.8M |
| RLMDRELMADA THERAPEUTICS, INC. | 633,901 | $4.4M |